Christian Meisel
Molecular Health has appointed Christian Meisel as its chief medical officer. Prior to Molecular Health, Meisel worked at Roche, where he served in multiple leadership roles including global head of its personalized healthcare platform, acting global head of translational medicine oncology, and global head of biomarkers and translational R&D innovation.
Sun Kim
Centogene has appointed Sun Kim as its chief strategy and investor relations officer. Prior to Centogene, Kim served as head of corporate strategy at Shire Pharmaceuticals. Before Shire, Kim worked at Alcon for six years, where he served in multiple roles including head of strategy and general manager of Alcon Singapore.
Nancy White
Inagene Diagnostics has appointed Nancy White as its CEO. White joined the firm in January as VP of sales and marketing. Prior to Inagene, White held several management roles at Novartis and Novartis Oncology from 2008 to 2018, including VP and franchise head, retina, region LACan; as well as global team lead, advancing commercial excellence, innovative customer models. Before Novartis, White served in multiple roles at Allergan from 2003 to 2008. Prior to Allergan, she held roles at Eli Lilly from 1999 to 2003.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.